in its filing to the exchanges informed that it has received final ANDA approval from USFDA for Pramipexole Dihydrochloride tablets 0.125mg, 0.25mg, 0.5mg, 0.75mg, 1mg, and 1.5mg. The announcement was made after market hours on Friday.
With this, the company can market a generic version of Boehringer Ingelheim Pharmaceutical’s Mirapex Tablets, 0.125mg, 0.25mg, 0.5mg, 0.75mg, 1mg, and 1.5mg.
Pramipexole Dihydrochloride tablets are indicated for the treatment of Parkinson's disease and also for the treatment of moderate to severe primary restless legs syndrome (RLS), the company added in the press note.
Unichem Laboratories Ltd's share price ended at Rs192.10 on Friday, up by Rs1.65 or 0.87%, from its previous close of Rs190.45 on the BSE.
The scrip opened at Rs190.85 and touched a high and low of Rs194.90 and Rs189.70, respectively. A total of, 58,097 (NSE+BSE) shares have traded on the counter. The current market cap of the company is Rs1,352.06cr.